CDKN2A and central nervous system cancer: On the other hand, CDKN2A inhibits the CDK4/cyclin D1 complex and, in this way, the transition G1 → S. Hypermethylation-mediated silencing of RB1 and CDKN2A has been frequently observed in primary glioma tissues [80, 81].